Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure

Circulation: Cardiovascular Imaging

Volumn 4, Issue 1, 2011, Pages 59-66

  Mielniczuk, Lisa M ^a   Birnie, David ^a   Ziadi, Maria C ^a   DeKemp, Robert A ^a   DaSilva, Jean N ^a   Burwash, Ian ^a   Tang, Anthony T ^b   Davies, Ross A ^a   Haddad, Haissam ^a   Guo, Ann ^a   Aung, May ^a   Williams, Kathryn ^a   Ukkonen, Heikki ^c   Beanlands, Rob S B ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

FDG PET; Heart failure; Right ventricle

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18; RUBIDIUM 82; DIAGNOSTIC AGENT; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOMYOPATHY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GLUCOSE METABOLISM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SCINTIGRAPHY; SYSTOLIC BLOOD PRESSURE; COHORT ANALYSIS; HEART VENTRICLE; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; THREE DIMENSIONAL IMAGING;

AGED; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART FAILURE; HEART VENTRICLES; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 79952152657     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.905984     Document Type: Article

References (41)

1. Ristow B, Ali S, Ren X, Whooley MA, Schiller NB. Elevated pulmonary artery pressure by Doppler echocardiography predicts hospitalization for heart failure and mortality in ambulatory stable coronary artery disease: the Heart and Soul Study. J Am Coll Cardiol. 2007;49:43- 49. (Pubitemid 46026900)
2. Ghio S, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini F, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183-188. (Pubitemid 32051736)
3. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G, American College of Chest Physicians. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126:78S-92S. (Pubitemid 38932344)
4. Massie BM, Schaefer S, Garcia J, McKirnan MD, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 1995;91:1814 -1823.
5. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy: relationship to contractile performance. Circ Res. 1996;78:893-902. (Pubitemid 26131374)
6. Barger PM, Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci. 1999;318: 36-42. (Pubitemid 30387273)
7. Chandler MP, Kerner J, Huang H. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol. 1994;287:H1538-H1543.
8. Osorio JC, Stanley WC, Linke A. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-α in pacing-induced heart failure. Circulation. 2002;106:606-612. (Pubitemid 34827712)
9. Kalsi KK, Smolenski RT, Pritchard RD, Khaghani A, Seymour AM, Yacoub MH. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Eur J Clin Invest. 1999;29:469-477. (Pubitemid 29271636)
10. Razegh P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation. 2001;104:2923-2931. (Pubitemid 33139104)
11. 18F] FDG in patients with congestive heart failure. J Nucl Med. 2001;42:55- 62. (Pubitemid 32104778)
12. Adrogue JV, Sharma S, Ngumbela K, Essop MF, Taegtmeyer H. Acclimatization to chronic hypobaric hypoxia is associated with a differential transcriptional profile between the right and left ventricle. Mol Cell Biochem. 2005;278:71-78. (Pubitemid 41418921)
13. Zaffran S, Kelly RG, Meilhac SM, Buckingham ME, Brown NA. Right ventricular myocardium derives from the anterior heart field. Circ Res. 2004;95:261-268. (Pubitemid 39056286)
14. Baudet S, Kuznetsov A, Merciai N, Gorza L, Ventura-Clapier R. Biochemical, mechanical and energetic characterization of right ventricular hypertrophy in the ferret heart. J Mol Cell Cardiol. 1994;26:1573-1586.
15. Bristow MR, Zisman LS, Lowes BD. The pressure-overloaded right ventricle in pulmonary hypertension. Chest. 1998;114:101S-106S. (Pubitemid 28334888)
16. Taegtmeyer H. Genetics of energetics: transcriptional responses in cardiac metabolism. Ann Biomed Eng. 2000;28:871- 876. (Pubitemid 32085371)
17. Birnie D, deKemp R, Ruddy T, Tang AT, Guo A, Williams K, Wassenar R, Beanlands R. Effect of lateral wall scar on reverse remodeling with cardiac resychronization therapy. Heart Rhythm. 2009;6:1721-1726.
18. Ziadi MC, deKemp RA, Renaud JM, Etele J, Guo A, Williams K, Davies RA, Chow B, Ruddy RD, Hessian R, DaSilva J, Iwanochko M, Marriott C, Wisenberg G, Ficaro EP, Garrard L, Beanlands RSB. PET imaging positively impacts management direction and predicts outcome in a multicenter 'real world' setting. Circulation. 2009;120:S349.
19. Teresa SM, Tsang TS. In: Murphy JG, Lloyd MA, eds. Principles of Echocardiography, 3rd ed. London Informa Healthcare; 2007;0267: 117-142.
20. Wackers FJTh, Bruni W, Zaret BL. Planar equilibrium radionuclide angiocardiography: acquisition and processing protocols: In: Nuclear Cardiology: The Basics. Totowa, NJ: Humana; 2003:81.
21. Starling MR, Dell'Italia DJ, Walsh RA, Little WC, Benedetto AR, Nusynowitz ML. Accurate estimates of absolute ventricular volumes from equilibrium radionuclide angiographic count data using a simple geometric attenuation correction. J Am Coll Cardiol. 1984;3:789 -792.
22. Zaret BL. Cardiac performance. In: Zaret BL, Beller GA, eds. Clinical Nuclear Cardiology: State of the Art and Future Directions. 3rd ed. Philadelphia: Elsevier; 2010:175-187.
23. Schelbert HR, Beanlands R, Bengel F, Knuuti J, Dicarli M, Machac J, Patterson R. PET myocardial perfusion and glucose metabolism imaging, part 2: guidelines for interpretation and reporting. J Nucl Cardiol. 2003; 10:557-571. (Pubitemid 37327979)
24. Yoshinaga K, Chow BJ, Willaims K, Chen L, deKemp RA, Garrard L, Lok-Tin Szeto A, Aung M, Davies RA, Ruddy T, Beanlands R. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48:1029 -1039. (Pubitemid 44292462)
25. Beanlands RS, Ruddy TD, deKemp RA, Iwanochko RM, Coates G, Freeman M, Nahmias C, Hendry P, Burns RJ, Lamy A, Mickelborough L, Kostuk W, Fallen E, Nichol G. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40:1735-1743. (Pubitemid 35341950)
26. Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, Bergmann SR, Brunken RC, Case J, Delbeke D, DiCarli MF, Garcia EV, Goldstein RA, Gropler RJ, Travin M, Patterson R, Schelbert HR. Quality Assurance Committee of the American Society of Nuclear Cardiology. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol. 2006;13:e121- e151. (Pubitemid 44913647)
27. 18F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med. 2001;42:1730-1736. (Pubitemid 34016339)
28. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM. PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002-2012. (Pubitemid 350054917)
29. deKemp RA, Nahmias C. Automated determination of the left ventricular long axis in cardiac positron emission tomography. Physiol Meas. 1996; 17:95-108. (Pubitemid 26178577)
30. 18F] fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005;45:1849 -1855. (Pubitemid 40779867)
31. Kantor PF, Robertson MA, Coe J, Lopaschuk GD. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol. 1999;33:1724 -1734.
32. Christie ME, Rogers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 1994; 26:1371-1375.
33. Davila-Roman VG, Vedala G, Herrero, de las Fuentes L, Rogers J, Kelly DP, Gropler RJ. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271-277. (Pubitemid 34756287)
34. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial phosphocreatineto- ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96:2190 -2196. (Pubitemid 27425822)
35. Chiu HC, Kovacs A, Ford DA, Hsu F, Garcia R, Herrero P, Saffitz JE, Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001;107:813- 822. (Pubitemid 32274034)
36. Takeyama D, Kagaya Y, Yamane Y, Shiba N, Chida M, Takahashi T, Ido T, Ishide N, Takishima T. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. Cardiovasc Res. 1995;29:763-767.
37. Kluge R, Barthel H, Pankau H, Seese A, Schauer J, Wirtz H, Seyfarth H, Steinbach J, Sabri O, Winkler J. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med. 2005;46:25-31. (Pubitemid 43085993)
38. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26: 357-366. (Pubitemid 26011184)
39. Benza R, Biederman R, Murali S, Gupta H. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2008;52:1683-1692.
40. Mukerjee D, St George D, Knight C, Davar J, Wells AU, duBois RM, Black CM, Coghlan JG. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology. 2004;43:461- 466. (Pubitemid 38489363)
41. 18F-FDG dynamic positron tomography and three-compartment analysis. Eur J Nucl Med Mol Imag. 2005;32:806-812. (Pubitemid 41125423)